Position in OMER
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,236,300
+$1,236,300 QoQ
Shares Held
130,000
Ownership
0.180%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#33
of 172 holders
Holding Since
Sep 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OMER Over Time
Shares Held
Position Value (USD)
Derivatives in OMER
reported options exposure · as of Jun 30, 2026CallValue
$1,145,004
CallShares
120,400
PutValue
$3,462,591
PutShares
364,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Caption Management, LLC holds $249,760,911 across 78 Biotechnology names. OMER ranks #39 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGON |
CG Oncology, Inc.
|
484,461 | $34,420,954 | |
| 2 | INSM |
INSMED Inc
|
236,000 | $25,162,320 | |
| 3 | ERAS |
Erasca, Inc.
|
1,041,225 | $19,075,242 | |
| 4 | CELC |
Celcuity Inc.
|
170,000 | $17,785,400 | |
| 5 | DSGN |
Design Therapeutics, Inc.
|
1,118,098 | $16,178,878 | |
| 6 | MLYS |
Mineralys Therapeutics, Inc.
|
413,087 | $11,145,087 | |
| 7 | REPL |
Replimune Group, Inc.
|
783,873 | $8,677,474 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
120,700 | $7,596,858 |
All Filings in OMER
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,145,004 | 120,400 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $3,462,591 | 364,100 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $1,236,300 | 130,000 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $8,172,526 | 475,700 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $1,332,500 | 325,000 | Put | Sole | 2025-11-14 | |
| 2024-12-31 | $1,669,720 | 169,000 | Call | Sole | 2025-02-14 | |
| 2021-12-31 | $482,250 | 75,000 | Put | Sole | 2022-02-11 | |
| 2021-12-31 | $1,965,008 | 305,600 | Call | Sole | 2022-02-11 | |
| 2021-09-30 | $1,462,484 | 106,054 | Shares | Sole | 2021-11-12 | |
| 2021-09-30 | $7,825,825 | 567,500 | Call | Sole | 2021-11-12 | |
| 2021-09-30 | $5,722,850 | 415,000 | Put | Sole | 2021-11-12 | |
| 2021-06-30 | $4,081,000 | 275,000 | Put | Sole | 2021-08-16 | |
| 2021-06-30 | $7,141,008 | 481,200 | Call | Sole | 2021-08-16 | |
| 2021-06-30 | $3,302,953 | 222,571 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,307,542 | 185,817 | Shares | Sole | 2021-05-17 | |
| 2021-03-31 | $2,944,120 | 165,400 | Put | Sole | 2021-05-17 | |
| 2021-03-31 | $4,186,560 | 235,200 | Call | Sole | 2021-05-17 | |
| 2020-12-31 | $1,486,160 | 104,000 | Call | Sole | 2021-02-16 | |
| 2020-12-31 | $1,507,137 | 105,468 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,861,251 | 184,100 | Call | Sole | 2020-11-16 | |
| 2020-09-30 | $974,755 | 96,415 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||